ArticleMultiple sclerosis journal - experimental, translational and clinical

A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo.

Patrick Vermersch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.